
0:00
13:29
This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has significantly expanded.
Fler avsnitt från "Two Onc Docs"



Missa inte ett avsnitt av “Two Onc Docs” och prenumerera på det i GetPodcast-appen.








